Steady Expansion Forecast for Artificial Intelligence (AI) in Precision Medicine Market, Projected to Reach $9.06 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence (AI) in Precision Medicine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of artificial intelligence (AI) in precision medicine has experienced an exponential surge lately. The market is set to expand from $2.33 billion in 2024 to $2.98 billion in 2025, recording a compound annual growth rate (CAGR) of 28.0%. Factors contributing to the growth during the historical phase include the increasing availability of healthcare data, mounting burden of chronic diseases, advancements in genomic research, a heightened focus on personalized medicine, and the enhancement of computational power.

Artificial Intelligence (AI) in Precision Medicine Market Size Forecast: What's the Projected Valuation by 2029?
The market size for artificial intelligence (AI) in precision medicine is predicted to experience substantial growth in the near future, expanding to $9.06 billion by 2029 with a compound annual growth rate (CAGR) of 32.0%. This expected growth during the forecast period is due to factors such as the rise in precision medicine initiatives, the increased need for predictive analytics in the healthcare sector, the development of genomics-related therapies, and the augmentation of funding for AI in precision medicine research. Within the forecast period, key trends include the discovery of biomarkers driven by AI, the extensive application of natural language processing in healthcare, the distinct stratification of patients through AI, the optimization of clinical trials enabled by AI, and the development of personalized treatment strategies using AI-based decision support systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-precision-medicine-global-market-report

What Are the Drivers Transforming the Artificial Intelligence (AI) in Precision Medicine Market?
The widespread occurrence of chronic diseases and breathing-related issues is anticipated to fuel artificial intelligence's role in the precision medicine market. Chronic conditions are long-lasting ailments that demand continuous medical care, while respiratory diseases disrupt the functioning of the lungs and airways. Precision medicine uses artificial intelligence to diagnose and predict the health outcomes of individuals with respiratory problems based on clinical data and chest scans. This technique is also effective in treating chronic diseases as it aids in cutting down expenses and maximizes the use of resources. For example, in May 2023, the United Nations, a US-based intergovernmental organization, predicted that by 2050, chronic conditions like heart disease, cancer, diabetes, and respiratory issues would cause 86% of the estimated 90 million deaths. Furthermore, in June 2024, the Australian Institute of Health and Welfare reported an increase in death rates connected with chronic diseases from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Thus, the significant incidence of chronic diseases and respiratory problems will enhance the value of artificial intelligence in the precision medicine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12572&type=smp

What Long-Term Trends Will Define the Future of the Artificial Intelligence (AI) in Precision Medicine Market?
One significant trend rising in prominence in the artificial intelligence in the precision medicine market is the creation of innovative AI-based solutions for life sciences. Leading companies in this market are making strides in big data analytics to maintain their market standing. An illustration of this is Google LLC, a US-centric technology firm, which in May 2023, launched an AI-driven solution for life sciences, intended to accelerate the processes of drug discovery and precision medicine. Their suite for target and lead identification, crafted to enhance the efficacy of in silico drug development, supports research teams in predicting protein structures and pinpointing amino acid functions with greater accuracy.

Which Segments in the Artificial Intelligence (AI) in Precision Medicine Market Offer the Most Profit Potential?
The artificial intelligence (ai) in precision medicinemarket covered in this report is segmented -

1) By Component: Hardware, Software, Service
2) By Technology: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing
3) By Therapeutic Application: Oncology, Cardiology, Neurology, Respiratory, Other Therapeutic Applications

Subsegments:
1) By Hardware: AI Processors, High-Performance Computing Systems, Diagnostic Devices
2) By Software: AI Algorithms And Models, Data Analytics Platforms, Genomic Analysis Software, Clinical Decision Support Systems
3) By Service: Consulting Services, Integration Services, Maintenance And Support Services, Training And Education Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12572&type=smp

Which Firms Dominate the Artificial Intelligence (AI) in Precision Medicine Market by Market Share and Revenue in 2025?
Major companies operating in the artificial intelligence (AI) in precision medicine market include Alphabet Inc., Microsoft Corporation, Intel Corporation, International Business Machines Corporation, AstraZeneca PLC, Sanofi S.A., NVIDIA Corporation, GE HealthCare Technologies Inc., Illumina Inc., QIAGEN N.V., Helix Inc., Sema4 Holdings Corp., SOPHiA GENETICS SA, Insilico Medicine, BenevolentAI Limited, Fabric Genomics Inc., Tempus Technologies Inc., Enlitic Inc., PathAI Inc., Genuity Science Inc., BERG LLC, Perthera Inc., Vuno Inc., CureMetrix Inc., AITIA International Inc., Zephyr AI, Freenome Inc., PetaGene Ltd., Suki AI Inc., BioXcel Therapeutics Inc.

Which Regions Offer the Highest Growth Potential in the Artificial Intelligence (AI) in Precision Medicine Market?
North America was the largest region in the artificial intelligence (AI) in the precision medicine market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12572

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.